American Society of Hematology

SHERPA: Blue

People

  1. O'Reilly
    O'Reilly
  2. Zelenetz
    Zelenetz
  3. Moore
    Moore
  4. Castro-Malaspina
    Castro-Malaspina
  5. Jakubowski
    Jakubowski
  6. Kernan
    Kernan
  7. Papadopoulos
    Papadopoulos
  8. Sadelain
    Sadelain
  9. Scheinberg
    Scheinberg
  10. Young
    Young

Groups

  1. Department of Medicine (41)
  2. Center for Hematologic Malignancies (37)
  3. Sloan Kettering Institute Faculty (34)
  4. Hematologic Malignancies, Division of (33)
  5. GSK Faculty (28)
  6. Tow Center for Developmental Oncology (TCDO) (19)
  7. Pediatrics, Department of (18)
  8. Lymphoma (13)
  9. Survivorship Research (12)
  10. Cell Biology Program Faculty (11)
Search Within
  1. "1998"
  2. "Meeting abstract"
Formats
  1. Meeting Abstract (84)
Groups
  1. Department of Medicine (41)
  2. Center for Hematologic Malignancies (37)
  3. Sloan Kettering Institute Faculty (34)
  4. Hematologic Malignancies, Division of (33)
  5. GSK Faculty (28)
  6. Tow Center for Developmental Oncology (TCDO) (19)

More Groups

People
  1. Pier Pandolfi Derinaldis (13)
  2. Richard O'Reilly (11)
  3. Andrew Zelenetz (10)
  4. Raymond Warrell (9)
  5. Malcolm Moore (8)
  6. Trudy Small (7)

More People

Years
  1. 1998 (84)
Publications
  1. Blood (84)

Results (84)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Extended life span of human bone marrow endothelial cells transfected with human telomerase reverse transcriptase
    Meeting Abstract

    MacKenzie, K. L.; Franco, S.; Naiyer, A. J.; May, C.; Tan, C.; Peichev, M. A.; Sadelain, M.; Rafii, S.; Moore, M. A. S.
    Blood (1998)

    Fulltext@MSK | Save
  • Risk of acute and chronic graft versus host disease (GvHD) associated with donor leucocyte infusion (DLI) decreases with time following HLA matched SBA-E-T cell depleted marrow grafts
    Meeting Abstract

    Jakubowski, A.; Small, T. N.; Collins, N.; Papadopoulos, E.; O'Reilly, R. J.
    Blood (1998)

    Fulltext@MSK | Save
  • Rapid selection of EBV-lymphoma specific T cells by transduction early after sensitization with a retroviral vector encoding a mutant NGFR and herpes simplex virus thymidine kinase gene
    Meeting Abstract

    Koehne, G.; Gallardo, H. F.; Sadelain, M.; O'Reilly, R. J.
    Blood (1998)

    Fulltext@MSK | Save
  • Cytotoxicity of NK cell line (NK-92) against relapsed/refractory leukemias and involvement of LFA-1 antigen in the NK cell mediated cytolysis
    Meeting Abstract

    Yan, Y.; Guan, X. Q.; Steinherz, P.; O'Reilly, R. J.
    Blood (1998)

    Fulltext@MSK | Save
  • Role of NF-kappa B in the rescue of multiple myeloma cells from drug-induced apoptosis by bcl-2
    Meeting Abstract

    Feinman, R.; Siegel, D. S.; Thames, M.; Koury, J.; Barlogie, B.; Epstein, J.; Michaeli, J.
    Blood (1998)

    Fulltext@MSK | Save
  • Arsenic compounds induce apoptosis in multiple myeloma (MM), activate pro-caspase-3 but do not affect BCL2 family members
    Meeting Abstract

    Tang, B.; Bajenova, O.; Feinman-Siegel, R.; Childs, B.; Pearse, R.; Michaeli, J.
    Blood (1998)

    Fulltext@MSK | Save
  • Impact of initial response on disease progression following tandem peripheral blood stem-cell transplants (PBSCT) in patients (pts) with poor prognosis multiple myeloma (MM)
    Meeting Abstract

    Niesvizky, R.; Choy, C. G.; Fine, J.; Glassman, J.; Reich, L.; Straus, D.; Yahalom, J.; Zhu, A.; Michaeli, J.
    Blood (1998)

    Fulltext@MSK | Save
  • Identification and characterization of autologous natural killer cell clones with anti-tumor reactivity in childhood stage 4 neuroblastoma
    Meeting Abstract

    Vyas, Y.; Selvakumar, A.; Cheung, N. K. V.; Dupont, B.
    Blood (1998)

    Fulltext@MSK | Save
  • A novel familial congenital syndrome of myelodysplasia with isolated T-cell CD8 deficiency
    Meeting Abstract

    Boulad, F.; Small, T. N.; Kernan, N. A.; Gillio, A.; Szabolcs, P.; George, D.; Castro-Malaspina, H.; Regan, A.; Castanza, J.; O'Reilly, R. J.
    Blood (1998)

    Fulltext@MSK | Save
  • Potential for myeloablation with yttrium-90-labeled HuM195 (anti-CD33): A phase I trial in advanced myeloid leukemias
    Meeting Abstract

    Jurcic, J. G.; Divgi, C. R.; McDevitt, M. R.; Ma, D.; Sgouros, G.; Finn, R. D.; Larson, S. M.; Scheinberg, D. A.
    Blood (1998)

    Fulltext@MSK | Save